Incyte Corporation (LON:0J9P)
London · Delayed Price · Currency is GBP · Price in USD 83.62
+0.41 (0.49%)
At close: Sep 16, 2025
Incyte Market Cap
Incyte has a market cap or net worth of 12.12 billion as of September 17, 2025. Its market cap has increased by 25.67% in one year.
Market Cap
12.12B
Enterprise Value
10.38B
Revenue
3.35B
Ranking
n/a
PE Ratio
19.07
Stock Price
83.62
Market Cap Chart
Since November 4, 1993, Incyte's market cap has increased from 30.86M to 12.12B, an increase of 39,175.34%. That is a compound annual growth rate of 20.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 12.01B | 12.95% |
| Dec 31, 2024 | 10.63B | -3.79% |
| Dec 29, 2023 | 11.05B | -25.51% |
| Dec 30, 2022 | 14.83B | 23.86% |
| Dec 31, 2021 | 11.97B | -14.18% |
| Dec 31, 2020 | 13.95B | -1.76% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 175.94B |
| GSK plc | 58.89B |
| Haleon | 31.92B |
| Smith & Nephew | 12.02B |
| ConvaTec Group | 4.70B |
| Hikma Pharmaceuticals | 3.56B |
| HUTCHMED (China) | 2.12B |
| Genus | 1.65B |